CTSL and Alzheimer disease: No significant differences in mRNA expression of ACE-2, TMPRSS2, CTSL, BSG, Furin, and NRP-1 were observed between the cells derived from cognitively healthy control subjects and AD individuals in mock-treated or SARS-CoV-2 infected samples (Fig. 3e).